Ticker

Analyst Price Targets — IVF

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
February 10, 2026 12:47 pm—Maxim Group$20.00$5.78TheFly INVO Fertility upgraded to Buy from Hold at Maxim

Latest News for IVF

Head to Head Comparison: Agilon Health (NYSE:AGL) & INVO Fertility (NASDAQ:IVF)

INVO Fertility (NASDAQ: IVF - Get Free Report) and Agilon Health (NYSE: AGL - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk. Analyst Recommendations This is a summary of

Defense World • Oct 11, 2026
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference,…

GlobeNewsWire • Sep 25, 2026
Financial Analysis: INVO Fertility (NASDAQ:IVF) vs. P3 Health Partners (NASDAQ:PIIIW)

P3 Health Partners (NASDAQ: PIIIW - Get Free Report) and INVO Fertility (NASDAQ: IVF - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability. Analyst Recommendations This is a breakdown of

Defense World • Sep 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for IVF.

No House trades found for IVF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top